PGT-A – Preimplantation Genetic Testing For Aneuploidies
PGT-A (preimplantation genetic testing for aneuploidies) is an IVF technology that analyzes embryo chromosomes to identify those with the correct number (46), thereby increasing pregnancy rates and reducing miscarriage risk and chromosomal abnormalities. It’s particularly recommended for women over 35, those with recurrent miscarriages or failed IVF cycles, severe male factor infertility, or a history of chromosomal issues.
FAQS - FREQUENTLY ASKED QUESTIONS
Everything You Need to Know In-house Preimplantation Genetic Testing
What is the main goal of PGT-A?
The primary goal of PGT-A is to identify embryos that have the correct number of chromosomes (46). By selecting these chromosomally normal embryos, PGT-A aims to increase pregnancy rates and reduce the risk of miscarriage and chromosomal abnormalities.
What are the benefits of Using PGT-A?
The benefits of using PGT-A include higher chances of a successful pregnancy, a reduced risk of miscarriage, and a decreased likelihood of having a child with a chromosomal abnormality
Who is typically recomended to undergo PGT-A?
PGT-A is particularly recommended for several groups of individuals. These include women over the age of 35, individuals with a history of recurrent miscarriages, those who have experienced previous failed IVF cycles, couples facing severe male factor infertility, or individuals with a known history of chromosomal issues.